Pursuant to Regulation 29(1) of SEBI(LODR) Regulation, 2015, Jenburkt Pharmaceuticals has informed about a meeting of the Board of Directors of the Company is scheduled to be held on 9th September, 2017, to consider matters related to Buyback of the Company’s fully paid up equity shares.
The above information is a part of company’s filings submitted to BSE.